Quality of Life in Patients with Metastatic or Unresectable Melanoma: Is Monotherapy with Nivolumab Preferred Over Combination Therapy?. (2024). Revista Médica De Trujillo, 19(3), 092-097. https://doi.org/10.17268/rmt.2024.v19i3.6141